Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Orthocell.
RELATED STOCKHEAD STORIES
News
Want to find another Splitit or Orthocell? Your best bet is… patience
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
The caps will stay, but here’s how Labor’s R&D reform might fire up Aussie innovation again
News
Lunchtime ASX small cap wrap: Who’s living in the wowser state today?
Health & Biotech
Health: Patients are saying Orthocell has fixed their damaged nerves, shares go ballistic
News
Lunchtime ASX small cap wrap: Who’s thankful for what they’ve got today?
News
Tl;dr? Here are your Budget cliff notes on what’s in store for ASX small caps
Health & Biotech
Stem cell biotech companies welcome $150 million in decade-long funding
Health & Biotech
8 out of 10 patients left on the scrapheap love Orthocell’s tendon-repairing technology
Health & Biotech
Fliers, flameouts and fakers: what happened in biotechland in 2018
Health & Biotech
Orthocell gets its grow-your-own-jawbone tech into a UK hospital
News
Lunchtime ASX small cap wrap: who’s climbing a mountain today
Health & Biotech
Orthocell says tests show its artificial membrane speeds up bone regeneration
Health & Biotech
Which of these ASX-listed stem cell stocks will make the next breakthrough?
Health & Biotech
Orthocell says it can grow you a 26pc better jaw bone
Health & Biotech
Allegra and Orthocell win government cash to research 3D body part printing
Health & Biotech